$OSCR

Oscar Health expands to 21 states, adds South Carolina market

Oscar Health (NYSE:OSCR) is expanding its 2027 health insurance offerings to 21 states, including South Carolina, covering 713 counties. The company introduced RetireEase for early retirees and expanded HelloMeno for menopause care. It also partnered with Allstate Health Solutions and added 250 new plans with bundled dental and vision coverage. Enrollment begins November 1, 2026.

Original reporting
Published Oct 20, 2026, 10:12 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 20, 2026, 10:18 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$OSCR
Bullish
high confidence
Mentioned
$OSCR
Relevance
6/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$OSCRBullishMed
01

Why it matters

The new state coverage and product suite aim to capture more individual and employer‑funded customers, potentially increasing premium volume.

02

Market read

First‑report of Oscar Health's multi‑state expansion, a material corporate development that could affect its stock price.

03

What to watch

Regulatory approvals in new states and integration of new AI health guide may face delays.

Relevance 6/10Novelty 6/10Timing: today

Background

Oscar Health is a U.S. health‑insurance provider focused on technology‑driven plans. The company has been expanding its footprint since its IPO.

Company-level read

Ticker impact

$OSCRBullishHigh confidence
Context

Oscar Health announced expansion to 21 states and new health plans, adding 250+ products and entering South Carolina.

Expected impact

likely pressure as the market prices in growth from new state coverage and product launches

Evidence & confidence

First‑report of a sizable geographic and product rollout; investors typically reward insurers for market expansion.

Market effects

May improve outlook for health‑insurance sector as competition intensifies with broader coverage options.

Adds competitive pressure in Southeast and Midwest insurance markets.

Limited to U.S. health‑insurance market.

Counterpoint

Expansion could strain capital and operational resources, potentially diluting margins in the short term.

Key entities

  • Oscar Health, Inc.

    U.S. health‑insurance provider expanding to 21 states.

  • Allstate Health Solutions

    Partnered with Oscar to offer supplemental cash‑pay options.

Related articles

$OSCRMed

OSCR Maintained by UBS -- Price Target Raised to $36

UBS maintained a 'Neutral' rating for Oscar Health (OSCR) but raised its price target to $36 from $26. GuruFocus values OSCR at $24.66, suggesting it is 37.9% overvalued at $34.01. The company has a GF Score of 81/100, with strong growth and momentum but concerns over valuation and profitability. Insiders have sold $26.76M in shares over the past three months.

$OSCRHighAI 8/10

OSCR Looks 33.9% Overvalued on GF Value™ as Oscar Health Revises

Oscar Health (OSCR) revised its 2026 forecasts, raising operating earnings outlook by $100M to $600M-$800M and improving medical loss ratio guidance. Revenue guidance remains $18.7B-$19B. GF Value™ indicates OSCR is 33.9% overvalued at $32.44. The company has a strong GF Score™ of 83/100, with high growth and momentum ratings but middling profitability and valuation. Insiders have sold significantly more shares than they've bought.

$OSCRHighAI 8/10

Oscar Health boosts 2026 earnings outlook, affirms revenue

Oscar Health (OSCR) updated its 2026 earnings outlook, lowering its Medical Loss Ratio to 81.0%-82.0% and raising earnings from operations to $600M-$800M. The company reaffirmed revenue guidance of $18.7B-$19.0B and maintained SG&A expense ratio targets. The updates will be discussed at its 2026 Investor Day on September 16, 2026.